Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers

Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers

Clinical data and longitudinal serum samples from the Mount Sinai Acute GVHD International Consortium (MAGIC) were used to develop MAGIC Algorithm Probability (MAP) that accurately predicts the risk of severe GVHD and non-relapse mortality. Dr. Ferrara explains how to interpret serum MAPs before and after GVHD treatment, the relationship of the serum MAP to GI GVHD pathology, and how MAPs can guide treatment for acute GVHD.


Published

February 6, 2020

Created by

Physician's Channel - Mount Sinai New York

Featured Faculty

James Ferrara, MD, DSc

James Ferrara, MD, DSc

Ward-Coleman Chair in Cancer Medicine
Professor and Director, Hematologic Malignancies Translational
Research Center
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai

View full profile